1. Home
  2. STIM vs CLNN Comparison

STIM vs CLNN Comparison

Compare STIM & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STIM
  • CLNN
  • Stock Information
  • Founded
  • STIM 2003
  • CLNN 2012
  • Country
  • STIM United States
  • CLNN United States
  • Employees
  • STIM N/A
  • CLNN N/A
  • Industry
  • STIM Medical/Dental Instruments
  • CLNN Biotechnology: Pharmaceutical Preparations
  • Sector
  • STIM Health Care
  • CLNN Health Care
  • Exchange
  • STIM Nasdaq
  • CLNN Nasdaq
  • Market Cap
  • STIM 36.1M
  • CLNN 43.0M
  • IPO Year
  • STIM 2018
  • CLNN N/A
  • Fundamental
  • Price
  • STIM $1.39
  • CLNN $4.40
  • Analyst Decision
  • STIM Buy
  • CLNN Strong Buy
  • Analyst Count
  • STIM 4
  • CLNN 4
  • Target Price
  • STIM $4.67
  • CLNN $55.25
  • AVG Volume (30 Days)
  • STIM 256.8K
  • CLNN 114.1K
  • Earning Date
  • STIM 11-12-2024
  • CLNN 11-13-2024
  • Dividend Yield
  • STIM N/A
  • CLNN N/A
  • EPS Growth
  • STIM N/A
  • CLNN N/A
  • EPS
  • STIM N/A
  • CLNN N/A
  • Revenue
  • STIM $72,711,000.00
  • CLNN $421,000.00
  • Revenue This Year
  • STIM $1.97
  • CLNN N/A
  • Revenue Next Year
  • STIM $7.96
  • CLNN N/A
  • P/E Ratio
  • STIM N/A
  • CLNN N/A
  • Revenue Growth
  • STIM 5.03
  • CLNN N/A
  • 52 Week Low
  • STIM $0.52
  • CLNN $3.82
  • 52 Week High
  • STIM $5.07
  • CLNN $11.00
  • Technical
  • Relative Strength Index (RSI)
  • STIM 64.78
  • CLNN 45.63
  • Support Level
  • STIM $1.23
  • CLNN $4.04
  • Resistance Level
  • STIM $1.58
  • CLNN $5.47
  • Average True Range (ATR)
  • STIM 0.16
  • CLNN 0.47
  • MACD
  • STIM 0.02
  • CLNN 0.02
  • Stochastic Oscillator
  • STIM 67.18
  • CLNN 29.61

About STIM Neuronetics Inc.

Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.

About CLNN Clene Inc.

Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements).

Share on Social Networks: